Triple agonists, as the name suggests, add a third ingredient to the mix
71,72 From a clinical perspective, these conflicting data suggest that motility-related adverse events are uncommon but may occur in susceptible individuals, particularly with prolonged exposure or in the presence of pre-existing GI motility disorders
Who should avoid IGF-1 LR3 Certain individuals should not use IGF-1 LR3 under any circumstances: Absolute Contraindications : Active cancer or history of hormone-sensitive tumors Severe diabetes or uncontrolled blood sugar Pregnancy or nursing mothers History of organ enlargement Active blood clotting disorders Relative Contraindications (may require specialty medical clearance): History of diabetes Cardiovascular conditions Autoimmune disorders Kidney or liver dysfunction History of growth disorders Before starting IGF-1 LR3, comprehensive health screening is essential
To minimize side effects, including bloating and other GI symptoms, when taking creatine, its best to stick to smaller maintenance doses, choose a high-quality micronized creatine, and make sure its fully dissolved before drinking